| Completed | Study to Evaluate Multiple Doses of Fluconazole, a CYP3A4 and CYP2C9 Inhibitor, on the Pharmacokinetics of CTP Health Volunteers | Phase 1 | 2022-07-11 |
| Completed | Study To Evaluate The Effect Of Multiple Doses of CTP-543 On The Pharmacokinetics Of Single Doses of Midazolam Health Volunteers | Phase 1 | 2022-06-21 |
| Completed | Study of the Effect of Food on the Bioavailability of the To-Be-Marketed Formulation of CTP-543 in Healthy Vol Health Volunteers | Phase 1 | 2022-06-14 |
| Completed | Study to Assess the Effect of Renal Impairment on the Pharmacokinetics of CTP-543 Renal Impairment | Phase 1 | 2022-06-06 |
| Completed | Study to Assess the Effect of Hepatic Impairment on the Pharmacokinetics of CTP-543 Hepatic Impairment | Phase 1 | 2022-06-01 |
| Completed | A Randomized Study to Evaluate the Effects of CTP-543 on the QT/QTc Intervals in Health Volunteers Healthy Volunteers | Phase 1 | 2022-01-04 |
| Completed | Study to Evaluate the Efficacy and Safety of CTP-543 in Adults With Moderate to Severe Alopecia Areata (THRIVE Alopecia Areata | Phase 3 | 2021-06-10 |
| Completed | Drug-drug Interaction Study of CTP-543 and Rifampin in Healthy Adult Subjects Healthy Volunteers | Phase 1 | 2021-05-19 |
| Completed | Drug-drug Interaction Study of CTP-543 and Itraconazole in Healthy Adult Subjects Healthy Volunteers | Phase 1 | 2021-03-02 |
| Completed | A Study to Evaluate the Durability of Response of CTP-543 in Adult Patients With Moderate to Severe Alopecia A Alopecia Areata | Phase 2 | 2021-02-26 |
| Completed | Study to Evaluate the Efficacy and Safety of CTP-543 in Adults With Moderate to Severe Alopecia Areata (THRIVE Alopecia Areata | Phase 3 | 2020-11-23 |
| Completed | Drug-drug Interaction Study of CTP-543 and Oral Contraceptives in Healthy Female Subjects Healthy Volunteers | Phase 1 | 2020-06-09 |
| Completed | A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-692 as an Adjunctive Treatment in Adults With Schiz Schizophrenia | Phase 2 | 2019-11-26 |
| Completed | Study Evaluating Pharmacokinetics and Mass Balance of [14C]-CTP-543 in Healthy Adult Male Volunteers Healthy Volunteers | Phase 1 | 2019-09-05 |
| Completed | Efficacy and Tolerability Study of Two Dosing Regimens of CTP-543 in Adults With Alopecia Areata Alopecia Areata | Phase 2 | 2019-05-24 |
| Completed | Multiple Ascending Dose Study of CTP-692 in Healthy Volunteers Healthy | Phase 1 | 2019-04-10 |
| Completed | Food Effect Study of CTP-543 in Healthy Volunteers Healthy | Phase 1 | 2019-03-25 |
| Completed | Efficacy and Tolerability Study of Two Dose Regimens of CTP-543 in Adults With Alopecia Areata Alopecia Areata | Phase 2 | 2019-03-21 |
| Completed | Study to Assess the Safety and Pharmacokinetic (PK) of CTP-692 in Healthy Volunteers Healthy | Phase 1 | 2019-01-24 |
| Completed | A Study to Compare the Safety, Tolerability, and Pharmacokinetics of CTP-692 Versus D-serine in Healthy Volunt Healthy Volunteers | Phase 1 | 2018-12-14 |
| Completed | Study to Evaluate the Safety and Efficacy of CTP-543 in Adults With Moderate to Severe Alopecia Areata Alopecia Areata | Phase 2 | 2017-08-09 |
| Completed | Open-Label Crossover Study Comparing CTP-543 to Jakafi® Healthy | Phase 1 | 2016-11-01 |
| Completed | Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CTP-543 in Healthy Subjects Healthy | Phase 1 | 2016-05-01 |
| Completed | Food Effect Study of CTP-656 in Healthy Male Volunteers Healthy | Phase 1 | 2016-02-01 |
| Completed | Healthy Volunteer Solid Oral Dose and Multiple Ascending Dose Evaluation of CTP-656 Healthy | Phase 1 | 2015-11-01 |
| Completed | Study to Evaluate Safety, Tolerability and PK of C-10355 and C-10358 in Healthy Subjects Healthy | Phase 1 | 2015-03-01 |
| Completed | Multiple Ascending Dose Study in Healthy Volunteers Healthy | Phase 1 | 2015-03-01 |
| Completed | A Safety and Tolerability Study of CTP-730 in Healthy Volunteers Healthy | Phase 1 | 2014-09-01 |
| Completed | A Phase 1, Single Dose Study of JZP-386 to Evaluate Safety, Pharmacokinetics and Pharmacodynamics Narcolepsy, Excessive Daytime Sleepiness | Phase 1 | 2014-07-01 |
| Completed | A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Type 2 Diabetes Mellitus, Chronic Kidney Disease | Phase 2 | 2012-01-01 |
| Completed | Safety & Tolerability Study of CTP-499 in Patients With Moderate Chronic Kidney Disease Stage 3 Chronic Kidney Disease | Phase 1 | 2011-08-01 |
| Completed | Safety, Tolerability, and Pharmacokinetics (PK) of CTP-499 Diabetic Nephropathy | Phase 1 | 2011-03-01 |
| Completed | Pharmacokinetics, Safety & Tolerability of Isotopologs of Atazanavir (ATV), With Pharmacokinetic Comparison to Healthy Volunteers | Phase 1 | 2010-12-01 |